|Bid||0.8000 x 4000|
|Ask||1.1000 x 500|
|Day's Range||0.8750 - 0.9063|
|52 Week Range||0.8600 - 3.4800|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 1, 2017 - Nov 6, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||5.50|
NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Curis, Inc. (NASDAQ: CRIS ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 8:30 AM Eastern Time. To ...
NEW YORK, NY / ACCESSWIRE / November 6, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
LEXINGTON, Mass., Nov. 03, 2017-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced ...
LEXINGTON, Mass., Nov. 01, 2017-- Curis, Inc., a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced ...